Lomefloxacin activity against 2,813 clinical isolates: A collaborative study at three medical centers in Brazil
- 30 June 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (3) , 35-39
- https://doi.org/10.1016/0732-8893(89)90063-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacinAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolonesAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agentsAntimicrobial Agents and Chemotherapy, 1988
- Enterohepatic circulation of NY-198, a new difluorinated quinolone, in ratsAntimicrobial Agents and Chemotherapy, 1988
- In vitro and in vivo activity of NY-198, a new difluorinated quinoloneAntimicrobial Agents and Chemotherapy, 1987
- The fluoroquinolones: pharmacology, clinical uses, and toxicities in humansAntimicrobial Agents and Chemotherapy, 1985
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985